Bachem Holding AG (SWX:BANB)
Switzerland · Delayed Price · Currency is CHF 80.00
+0.35 (0.44%)
Nov 11, 2026, 12:40 PM CET
Bachem Holding AG Market Cap
Bachem Holding AG has a market cap or net worth of 5.99 billion as of November 10, 2026. It is the 2,728th most valuable company in the world and the 46th biggest in Switzerland. Its market cap has increased by 56.17% in one year.
Market Cap
5.99B
Enterprise Value
6.15B
Revenue
708.53M
Global Rank
Country Rank
#46 Switzerland
PE Ratio
40.33
ChartMarket Cap Chart
Since March 1, 1999, Bachem Holding AG's market cap has increased from 1.52B to 5.99B, an increase of 293.64%. That is a compound annual growth rate of 5.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 5.99B | 33.49% |
| Dec 30, 2025 | 4.49B | 3.45% |
| Dec 30, 2024 | 4.34B | -10.92% |
| Dec 29, 2023 | 4.87B | -17.25% |
| Dec 30, 2022 | 5.89B | -44.23% |
| Dec 30, 2021 | 10.56B | 90.80% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Idorsia | 1.12B |
| Basilea Pharmaceutica AG | 897.16M |
| Santhera Pharmaceuticals Holding AG | 232.67M |
| Newron Pharmaceuticals | 195.19M |
| BioVersys AG | 131.97M |
| Molecular Partners AG | 98.91M |
| Xlife Sciences AG | 49.60M |
| MindMaze Therapeutics Holding | 23.02M |